CoChat
Sign Up
Cited by 784Pain Mechanisms and TreatmentsNeurotransmitter Receptor Influence on BehaviorPain Management and Placebo Effect

The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.

A common neurobiology for pain and pleasure

Leknes, Siri, Tracey, Irene·2008·Nature Reviews Neuroscience
DOI 10.1038/nrn2333
Open this paper in CoChat — free account

Abstract

Pain and pleasure are powerful motivators of behaviour and have historically been considered opposites. Emerging evidence from the pain and reward research fields points to extensive similarities in the anatomical substrates of painful and pleasant sensations. Recent molecular-imaging and animal studies have demonstrated the important role of the opioid and dopamine systems in modulating both pain and pleasure. Understanding the mutually inhibitory effects that pain and reward processing have on each other, and the neural mechanisms that underpin such modulation, is important for alleviating unnecessary suffering and improving well-being.

Overview

Integrity signals

Registry

Crossref · 10.1038/nrn2333

Cites

0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Flagged first, then by citations

Show all 0 references

Research works printed but not linked: 97

  1. Petrovic, P., Kalso, E., Petersson, K. M. & Ingvar, M. Placebo and opioid analgesia — imaging a shared neuronal network. Science 295, 1737–1740 (2002). · DOI · Paper page
  2. Seymour, B., Daw, N., Dayan, P., Singer, T. & Dolan, R. Differential encoding of losses and gains in the human striatum. J. Neurosci. 27, 4826–4831 (2007). · DOI
  3. Cabanac, M. Sensory pleasure. Q. Rev. Biol. 54, 1–29 (1979). · DOI
  4. Bentham, J. An introduction to the principles of morals and legislation (Clarendon 1907) Accessible online at http://www.econlib.org/library/Bentham/bnthPML1.html .
  5. Cannon, W. B. The wisdom of the body (Norton and Co., New York, 1932).
  6. Kringelbach, M. L., O'Doherty, J., Rolls, E. T. & Andrews, C. Activation of the human orbitofrontal cortex to a liquid food stimulus is correlated with its subjective pleasantness. Cereb. Cortex 13, 1064–1071 (2003). · DOI · Paper page
  7. Craig, A. D. A new view of pain as a homeostatic emotion. Trends Neurosci. 26, 303–307 (2003). · DOI
  8. Leknes, S., Wiech, K., Brooks, J. C. W. & Tracey, I. Is there more to pain relief than a reduction in pain intensity? A psychophysical investigation. Eur. J. Pain 10, S78 (2006). · DOI
  9. Price, D. D., Harkins, S. W. & Baker, C. Sensory-affective relationships among different types of clinical and experimental pain. Pain 28, 297–307 (1987). · DOI · Paper page
  10. Harper, P. No pain, no gain: pain behaviour in the armed forces. Br. J. Nurs. 15, 548–551 (2006). · DOI
  11. Fields, H. L. in Proceedings of the 11th World Congress on Pain (eds Flor, H., Kalso, E. & Dostrovsky, J. O.) 449–459 (IASP Press, Seattle, 2006).
  12. Tracey, I. & Mantyh, P. W. The cerebral signature for pain perception and its modulation. Neuron 55, 377–391 (2007). · DOI · Paper page
  13. Dum, J. & Herz, A. Endorphinergic modulation of neural reward systems indicated by behavioral changes. Pharmacol. Biochem. Behav. 21, 259–266 (1984). · DOI
  14. Reboucas, E. C. et al. Effect of the blockade of μ1-opioid and 5HT2A-serotonergic/α1-noradrenergic receptors on sweet-substance-induced analgesia. Psychopharmacology (Berl.) 179, 349–55 (2005). · DOI
  15. Forsberg, G., Wiesenfeld-Hallin, Z., Eneroth, P. & Sodersten, P. Sexual behavior induces naloxone-reversible hypoalgesia in male rats. Neurosci. Lett. 81, 151–154 (1987). · DOI
  16. Szechtman, H., Hershkowitz, M. & Simantov, R. Sexual behavior decreases pain sensitivity and stimulated endogenous opioids in male rats. Eur. J. Pharmacol. 70, 279–285 (1981). · DOI
  17. Gear, R. W., Aley, K. O. & Levine, J. D. Pain-induced analgesia mediated by mesolimbic reward circuits. J. Neurosci. 19, 7175–7181 (1999). · DOI
  18. Villemure, C., Slotnick, B. M. & Bushnell, M. C. Effects of odors on pain perception: deciphering the roles of emotion and attention. Pain 106, 101–108 (2003). · DOI
  19. Kenntner-Mabiala, R. & Pauli, P. Affective modulation of brain potentials to painful and nonpainful stimuli. Psychophysiology 42, 559–567 (2005). · DOI
  20. Roy., M., Peretz, I. & Rainville, P. Emotional valence contributes to music-induced analgesia. Pain 134, 140–147 (2008). · DOI
  21. de la Fuente-Fernandez, R. et al. Expectation and dopamine release: mechanism of the placebo effect in Parkinson's disease. Science 293, 1164–1166 (2001). · DOI
  22. Benedetti, F., Mayberg, H. S., Wager, T. D., Stohler, C. S. & Zubieta, J.-K. Neurobiological mechanisms of the placebo effect. J. Neurosci. 25, 10390–10402 (2005). · DOI
  23. Stevenson, G. W., Bilsky, E. J. & Negus, S. S. Targeting pain-suppressed behaviors in preclinical assays of pain and analgesia: effects of morphine on acetic acid-suppressed feeding in C57BL/6J mice. J. Pain 7, 408–416 (2006). · DOI
  24. Narita, M. et al. Direct evidence for the involvement of the mesolimbic κ-opioid system in the morphine-induced rewarding effect under an inflammatory pain-like state. Neuropsychopharmacology 30, 111–118 (2004). · DOI · Paper page
  25. Marbach, J. J. & Lund, P. Depression, anhedonia and anxiety in temporomandibular joint and other facial pain syndromes. Pain 11, 73–84 (1981). · DOI
  26. Berridge, K. The debate over dopamine's role in reward: the case for incentive salience. Psychopharmacology 191, 391–431 (2007). · DOI · Paper page
  27. Berridge, K. C. Pleasures of the brain. Brain Cogn. 52, 106–128 (2003). · DOI
  28. Pecina, S., Cagniard, B., Berridge, K. C., Aldridge, J. W. & Zhuang, X. Hyperdopaminergic mutant mice have higher “wanting” but not “liking” for sweet rewards. J. Neurosci. 23, 9395–9402 (2003). · DOI · Paper page
  29. Hnasko, T. S., Sotak, B. N. & Palmiter, R. D. Morphine reward in dopamine-deficient mice. Nature 438, 854–857 (2005). · DOI · Paper page
  30. Barbano, M. F. & Cador, M. Differential regulation of the consummatory, motivational and anticipatory aspects of feeding behavior by dopaminergic and opioidergic drugs. Neuropsychopharmacology 31, 1371–1381 (2006). · DOI
  31. Barbano, M. & Cador, M. Opioids for hedonic experience and dopamine to get ready for it. Psychopharmacology 191, 497–506 (2007). · DOI
  32. Zubieta, J.-K. et al. Regional mu opioid receptor regulation of sensory and affective dimensions of pain. Science 293, 311–315 (2001). · DOI
  33. Murphy, M. R., Checkley, S. A., Seckl, J. R. & Lightman, S. L. Naloxone inhibits oxytocin release at orgasm in man. J. Clin. Endocrinol. Metab. 71, 1056–1058 (1990). · DOI
  34. Zhao, Z.-Q. et al. Central serotonergic neurons are differentially required for opioid analgesia but not for morphine tolerance or morphine reward. Proc. Natl Acad. Sci. USA 104, 14519–14524 (2007). · DOI
  35. Mucha, R. F. & Herz, A. Motivational properties of kappa and mu opioid receptor agonists studied with place and taste preference conditioning. Psychopharmacology 86, 274–280 (1985). · DOI
  36. Hirakawa, N., Tershner, S. A., Fields, H. L. & Manning, B. H. Bi-directional changes in affective state elicited by manipulation of medullary pain-modulatory circuitry. Neuroscience 100, 861–871 (2000). · DOI
  37. Schultz, W. Behavioral dopamine signals. Trends Neurosci. 30, 203–210 (2007). · DOI · Paper page
  38. Scott, D. J., Heitzeg, M. M., Koeppe, R. A., Stohler, C. S. & Zubieta, J.-K. Variations in the human pain stress experience mediated by ventral and dorsal basal ganglia dopamine activity. J. Neurosci. 26, 10789–10795 (2006). · DOI
  39. Ungless, M. A., Magill, P. J. & Bolam, J. P. Uniform inhibition of dopamine neurons in the ventral tegmental area by aversive stimuli. Science 303, 2040–2042 (2004). · DOI · Paper page
  40. Hagelberg, N. et al. Alfentanil increases cortical dopamine D2/D3 receptor binding in healthy subjects. Pain 109, 86–93 (2004). · DOI
  41. Wood, P. B. et al. Fibromyalgia patients show an abnormal dopamine response to pain. Eur. J. Neurosci. 25, 3576–3582 (2007). · DOI
  42. Altier, N. & Stewart, J. The role of dopamine in the nucleus accumbens in analgesia. Life Sci. 65, 2269–2287 (1999). · DOI · Paper page
  43. Gerdelat-Mas, A. et al. Levodopa raises objective pain threshold in Parkinson's disease: a RIII reflex study. J. Neurol. Neurosurg. Psychiatry 78, 1140–1142 (2007). · DOI
  44. Wood, P. B. Mesolimbic dopaminergic mechanisms and pain control. Pain 120, 230–234 (2006). · DOI
  45. Zubieta, J.-K. et al. COMT val158met genotype affects μ-opioid neurotransmitter responses to a pain stressor. Science 299, 1240–1243 (2003). · DOI
  46. Khachaturian, H. & Watson, S. J. Some perspectives on monoamine-opioid peptide interaction in rat central nervous system. Brain Res. Bull. 9, 441–462 (1982). · DOI
  47. Roth-Deri, I. et al. Effect of experimenter-delivered and self-administered cocaine on extracellular β-endorphin levels in the nucleus accumbens. J. Neurochem. 84, 930–938 (2003). · DOI
  48. King, M. A., Bradshaw, S., Chang, A. H., Pintar, J. E. & Pasternak, G. W. Potentiation of opioid analgesia in dopamine2 receptor knock-out mice: evidence for a tonically active anti-opioid system. J. Neurosci. 21, 7788–7792 (2001). · DOI
  49. Johnson, S. W. & North, R. A. Opioids excite dopamine neurons by hyperpolarization of local interneurons. J. Neurosci. 12, 483–488 (1992). · DOI · Paper page
  50. Nugent, F. S., Penick, E. C. & Kauer, J. A. Opioids block long-term potentiation of inhibitory synapses. Nature 446, 1086–1090 (2007). · DOI · Paper page
  51. Hagelberg, N. et al. μ-Receptor agonism with alfentanil increases striatal dopamine D2 receptor binding in man. Synapse 45, 25–30 (2002). · DOI
  52. Gray, J. A. & McNaughton, N. The neuropsychology of anxiety (Oxford Univ. Press, Oxford, 2000).
  53. Tindell, A. J., Smith, K. S., Pecina, S., Berridge, K. C. & Aldridge, J. W. Ventral pallidum firing codes hedonic reward: when a bad taste turns good. J. Neurophysiol. 96, 2399–2409 (2006). · DOI · Paper page
  54. Smith, K. S. & Berridge, K. C. Opioid limbic circuit for reward: interaction between hedonic hotspots of nucleus accumbens and ventral pallidum. J. Neurosci. 27, 1594–1605 (2007). · DOI · Paper page
  55. Miller, J. M. et al. Anhedonia after a selective bilateral lesion of the globus pallidus. Am. J. Psychiatry 163, 786–788 (2006). · DOI
  56. Bingel, U., Lorenz, J., Schoell, E., Weiller, C. & Buchel, C. Mechanisms of placebo analgesia: rACC recruitment of a subcortical antinociceptive network. Pain 120, 8–15 (2006). · DOI · Paper page
  57. Harris, R. E. et al. Decreased central μ-opioid receptor availability in fibromyalgia. J. Neurosci. 27, 10000–10006 (2007). · DOI
  58. Braz, J. M., Nassar, M. A., Wood, J. N. & Basbaum, A. I. Parallel “pain” pathways arise from subpopulations of primary afferent nociceptor. Neuron 47, 787–793 (2005). · DOI
  59. Reynolds, S. M. & Berridge, K. C. Positive and negative motivation in nucleus accumbens shell: bivalent rostrocaudal gradients for GABA-elicited eating, taste “liking”/“disliking” reactions, place preference/avoidance, and fear. J. Neurosci. 22, 7308–7320 (2002). · DOI · Paper page
  60. Rolls, E. T. et al. Representations of pleasant and painful touch in the human orbitofrontal and cingulate cortices. Cereb. Cortex 13, 308–317 (2003). · DOI · Paper page
  61. Tremblay, L. & Schultz, W. Relative reward preference in primate orbitofrontal cortex. Nature 398, 704–708 (1999). · DOI · Paper page
  62. Nutt, D. et al. The other face of depression, reduced positive affect: the role of catecholamines in causation and cure. J. Psychopharmacol. 21, 461–471 (2007). · DOI · Paper page
  63. Dawkins, L., Powell, J. H., West, R., Powell, J. & Pickering, A. A double-blind placebo controlled experimental study of nicotine: I—effects on incentive motivation. Psychopharmacology 189, 355–367 (2006). · DOI · Paper page
  64. de Vasconcellos, A. P. S., Nieto, F. B., Fontella, F. U., da Rocha, E. R. & Dalmaz, C. The nociceptive response of stressed and lithium-treated rats is differently modulated by different flavors. Physiol. Behav. 88, 382–388 (2006). · DOI
  65. Zubieta, J.-K. et al. Regulation of human affective responses by anterior cingulate and limbic μ-opioid neurotransmission. Arch. Gen. Psychiatry 60, 1145–1153 (2003). · DOI
  66. Seligman, M. in Handbook of Positive Psychology (eds Snyder, C. R. & Lopez, S. J.) (Oxford Univ. Press, New York, 2005).
  67. Driscoll, R. & Edwards, L. The misconception of Christian suffering. Pastoral Psychol. 32, 34–48 (1983). · DOI
  68. Nagel, T. What is it like to be a bat? Philos. Rev. 83, 435–450 (1974). · DOI · Paper page
  69. Price, D. D., Barrell, J. J. & Gracely, R. H. A psychophysical analysis of experiential factors that selectively influence the affective dimension of pain. Pain 8, 137–149 (1980). · DOI
  70. Lowe, M. R. & Butryn, M. L. Hedonic hunger: a new dimension of appetite? Physiol. Behav. 91, 432–439 (2007). · DOI
  71. Damasio, A. Descartes' Error: Emotion, Reason, and the Human Brain (Grosset/Putnam, New York, 1994).
  72. Peters, E., Västfjäll, D., Gärling, T. & Slovic, P. Affect and decision making: a 'hot' topic. J. Behav. Decision Making 19, 79–85 (2006). · DOI
  73. Harbaugh, W. T., Mayr, U. & Burghart, D. R. Neural responses to taxation and voluntary giving reveal motives for charitable donations. Science 316, 1622–1625 (2007). · DOI · Paper page
  74. Koob, G. F. & Moal, M. L. Drug abuse: hedonic homeostatic dysregulation. Science 278, 52–58 (1997). · DOI · Paper page
  75. Moss, J. in Oxford Studies in Ancient Philosophy (ed. Sedley, D.) (Oxford Univ. Press, USA, 2005).
  76. Ballantyne, J. C. & LaForge, K. S. Opioid dependence and addiction during opioid treatment of chronic pain. Pain 129, 235–255 (2007). · DOI
  77. Franken, I. H. A., Zijlstra, C. & Muris, P. Are nonpharmacological induced rewards related to anhedonia? A study among skydivers. Prog. Neuropsychopharmacol. Biol. Psychiatry 30, 297–300 (2006). · DOI
  78. Symons, F., Thompson, A. & Rodriguez, M. Self-injurious behavior and the efficacy of naltrexone treatment: a quantitative synthesis. Ment. Retard. Dev. Disabil. Res. Rev. 10, 193–200 (2004). · DOI
  79. Grace, A. A. Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: a hypothesis for the etiology of schizophrenia. Neuroscience 41, 1–24 (1991). · DOI · Paper page
  80. Gut-Fayand, A. et al. Substance abuse and suicidality in schizophrenia: a common risk factor linked to impulsivity. Psychiatry Res. 102, 65–72 (2001). · DOI
  81. Kringelbach, M. L., de Araujo, I. E. T. & Rolls, E. T. Taste-related activity in the human dorsolateral prefrontal cortex. Neuroimage 21, 781–788 (2004). · DOI
  82. Pelchat, M. L., Johnson, A., Chan, R., Valdez, J. & Ragland, J. D. Images of desire: food-craving activation during fMRI. Neuroimage 23, 1486–1493 (2004). · DOI · Paper page
  83. Brooks, J. C. W., Zambreanu, L., Godinez, A., Craig, A. D. & Tracey, I. Somatotopic organisation of the human insula to painful heat studied with high resolution functional imaging. Neuroimage 27, 201–209 (2005). · DOI · Paper page
  84. Wager, T. D. et al. Placebo-induced changes in fMRI in the anticipation and experience of pain. Science 303, 1162–1167 (2004). · DOI · Paper page
  85. Wittmann, M., Leland, D. & Paulus, M. Time and decision making: differential contribution of the posterior insular cortex and the striatum during a delay discounting task. Exp. Brain Res. 179, 643–653 (2007). · DOI
  86. Ostrowsky, K. et al. Representation of pain and somatic sensation in the human insula: a study of responses to direct electrical cortical stimulation. Cereb. Cortex 12, 376–385 (2002). · DOI
  87. Knutson, B., Fong, G. W., Bennett, S. M., Adams, C. M. & Hommer, D. A region of mesial prefrontal cortex tracks monetarily rewarding outcomes: characterization with rapid event-related fMRI. Neuroimage 18, 263–272 (2003). · DOI
  88. Porro, C. A., Cettolo, V., Francescato, M. P. & Baraldi, P. Functional activity mapping of the mesial hemispheric wall during anticipation of pain. Neuroimage 19, 1738–1747 (2003). · DOI
  89. Ochsner, K. N. et al. Neural correlates of individual differences in pain-related fear and anxiety. Pain 120, 69–77 (2006). · DOI
  90. Shidara, M. & Richmond, B. J. Anterior cingulate: single neuronal signals related to degree of reward expectancy. Science 296, 1709–1711 (2002). · DOI
  91. Bingel, U., Glascher, J., Weiller, C. & Buchel, C. Somatotopic representation of nociceptive information in the putamen: an event-related fMRI study. Cereb. Cortex 14, 1340–1345 (2004). · DOI
  92. Menon, V. & Levitin, D. J. The rewards of music listening: response and physiological connectivity of the mesolimbic system. Neuroimage 28, 175–184 (2005). · DOI
  93. Bussone, G. et al. Deep brain stimulation in craniofacial pain: seven years' experience. Neurol. Sci. 28, S146–S149 (2007). · DOI
  94. Becerra, L., Breiter, H. C., Wise, R., Gonzalez, R. G. & Borsook, D. Reward circuitry activation by noxious thermal stimuli. Neuron 32, 927–946 (2001). · DOI
  95. Ramnani, N., Elliott, R., Athwal, B. S. & Passingham, R. E. Prediction error for free monetary reward in the human prefrontal cortex. Neuroimage 23, 777–786 (2004). · DOI
  96. Zambreanu, L., Wise, R. G., Brooks, J. C. W., Iannetti, G. D. & Tracey, I. A role for the brainstem in central sensitisation in humans. Evidence from functional magnetic resonance imaging. Pain 114, 397–407 (2005). · DOI
  97. Pecina, S. & Berridge, K. C. Brainstem mediates diazepam enhancement of palatability and feeding: microinjections into fourth ventricle versus lateral ventricle. Brain Res. 727, 22–30 (1996). · DOI

Cited by

Sorted by citations

Items 201–300 of 669

Metadata

Authors
Leknes, S., & Tracey, I.
Affiliations
John Radcliffe Hospital (GB)
Corresponding author
Tracey, Irene
ORCID
Venue
Nature Reviews Neuroscience
Publisher
Springer Science and Business Media LLC
Published
2008-04
Volume
9
Issue
4
Pages
314-320
ISSN
  • 1471-003X (ISSN-L)
  • 1471-0048
DOI
10.1038/nrn2333
OpenAlex
W2050134288
Semantic Scholar
5c7a6d152be4a14216e5ff7dcd87fefc35df55fe
Cited by
784
References
0
Citations by year
2026: 43 · 2025: 33 · 2024: 48 · 2023: 31 · 2022: 61 · 2021: 42 · 2020: 47 · 2019: 49 · 2018: 46 · 2017: 52 · 2016: 52 · 2015: 53 · 2014: 45 · 2013: 59 · 2012: 39
FWCI
3.03
Type
journal article
Language
en
Open access
closed
Licence
www.springer.com/tdm (tdm)
Locations
  • Nature reviews. Neuroscience (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Wellcome Trust
  • Medical Research Council
Topics
  • Health Sciences › Medicine › Physiology (medical) › Pain Mechanisms and Treatments
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
  • Life Sciences › Neuroscience › Cognitive Neuroscience › Pain Management and Placebo Effect
Keywords
pain, pleasure, reward, opioid system, dopaminergic system, molecular imaging, well-being, suffering
MeSH terms
Animals, Emotions, Humans, Neurobiology, Pain, Pleasure-Pain Principle

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review